Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq PR Newswire SHANGHAI, Aug. 6, 2026 SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming...